Tag: ICG-001

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Small-molecule drug reduces chemoresistance of chronic myelogenous leukemia cells [PreClinical]

byChristine Yoonand1 others

December 29, 2015

1. The compound ICG-001 sensitized chemoresistant leukemia-initiating cells (LICs) to Imatinib (IM) and inhibited their ability to survive and ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

β-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction
Leqembi gains at home injection for maintenance dosing
Computed Tomographic Angiography and Yield for Gastrointestinal Bleeding in the Emergency Department

No Result

View All Result